Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Abstract Background World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active pharmacovigilance that allows for detection, reporting and management of adverse events. The ai...

Full description

Bibliographic Details
Main Authors: Jing-Tao Gao, Juan Du, Gui-Hui Wu, Yi Pei, Meng-Qiu Gao, Leonardo Martinez, Lin Fan, Wei Chen, Li Xie, Yu Chen, Hua Wang, Long Jin, Guo-Bao Li, Pei-Lan Zong, Yu Xiong, Qian-Hong Wu, Ming-Wu Li, Xiao-Feng Yan, Yan-Fang Miao, Qing-Shan Cai, Xin-Jie Li, Da-Peng Bai, Shu-Jun Geng, Guo-Li Yang, Pei-Jun Tang, Yi Zeng, Xiao-Hong Chen, Tong-Xia Li, Cui Cai, Yun Zhou, Ma Zhuo, Jian-Yun Wang, Wen-Long Guan, Lin Xu, Ji-Chan Shi, Wei Shu, Li-Li Cheng, Fei Teng, Yu-Jia Ning, Shi-Heng Xie, Yu-Xian Sun, Li-Jie Zhang, Yu-Hong Liu
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Infectious Diseases of Poverty
Subjects:
Tuberculosis
Multidrug-resistant
Bedaquiline
Safety
Surveillance program
China
Online Access:https://doi.org/10.1186/s40249-021-00819-2

Internet

https://doi.org/10.1186/s40249-021-00819-2

Similar Items